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the molecular links between the MR overexpressed in cardiomyocyte and this 
coronal phenotype remain to be clari¿ ed. 
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Corticosteroids have been involved in the genesis of ventricular arrhyth-
mias associated with pathological heart hypertrophy, but molecular mecha-
nisms responsible for these effects have not been completely described. Since 
Mineralocorticoid Receptor (MR) antagonists have been demonstrated to be 
clearly bene¿ c on the cardiac function in failing patients, much attention has 
been given to the speci¿ c action of aldosterone (aldo) on the heart.
We have previously observed that aldo and corticosterone induce in vitro a 
marked acceleration of the spontaneous contractions of isolated neonate rat ventri-
cular cardiomyocytes, a potential proarrythmogenic condition if occurring in vivo, 
as well as cell hypertrophy. On the other hand, the role of the steroid hormone 
DHEA in human health has been discussed a lot over last ten years but the mecha-
nism of its putative cardioprotective function has not been yet elucidated.
In this study we have found that DHEA reduce both chronotropic (cell beating 
frequency) and hypertrophic (cell size) effects of 24h-aldosterone stimulation of 
cardiomyocytes. These effects are accompanied by a marked decrease of T-type 
calcium channel expression (alpha1H subunit) and activity, a clearly identi¿ ed 
mediator of the aldo chronotropic response. Cell hypertrophy prevention was 
also determined by measuring the expression of genes coding for hypertrophic 
markers like ANP and BNP by qPCR. The kinetics of these responses to DHEA, 
and their sensitivity to actinomycin D, revealed the presence of both genomic 
and non genomic mechanisms. While the genomic action of DHEA appears 
involving the inhibition of both MR and GR (glucocorticoid receptor), the rapid, 
nongenomic response could be related to its anti-oxydant properties.
Altogether, these results suggest new mechanisms for a putative cardiopro-
tective role of DHEA in corticosteroids-associated heart diseases.
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Introduction: To explore the role of genetic variant of angiotensinogen 
(AGT) M235T as an independent risk factor for acute myocardial infarction 
(AMI) and to investigate the possible association with the severity of coronary 
artery disease (CAD), estimated on the basis of the number of coronary ste-
noses and critical arterial occlusions. 
Patients and methods: 123 AMI patients compared to 144 healthy 
controls. AGT genotypes were determined by PCR method.
Results: A signi¿ cant association was found between AGT M235T poly-
morphism and AMI (p=0.021). By logistic regression, the TT genotype 
appeared to confer 1.9-fold increased risk for AMI in both the univariate and 
the multivariate model. The frequencies of TT genotype and T allele increased 
with the number of stenoses in coronary vessels. Moreover, the TT genotype 
and the T allele were more frequent in the subgroup of patients with stenoses 
in at least four coronary vessels than in other patients including subjects with 
one to three vessel disease. Furthermore, the TT genotype and the T allele 
were signi¿ cantly more frequent in patients with critical arterial occlusions 
(>90%) than in subjects without critical stenoses. 
Conclusions: The AGT M235T polymorphism associates with AMI risk 
and inÀ uences CAD severity.  
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Recent studies have identi¿ ed genetic markers that may directly inÀ uence 
the risk of the coronary artery disease (CAD), in particular the renin angio-
tensin system genes. Since there are no existing data for the Tunisian popu-
lation, we investigated the association between these polymorphisms 
(angiotensin-converting enzyme [ACE] insertion/deletion [Ins/Del]; the angio-
tensinogen T174M and M235T; and the angiotensin II type 1 receptor A1166C 
polymorphisms) and CAD in Tunisians. Study subjects comprised 341 cases 
and 316 age- and sex-matched healthy individuals. Clinical characteristics and 
other biochemical and environmental risk factors were collected for both. The 
distribution of the Ins/Del genotypes was signi¿ cantly different between cases 
and controls (p=0.049) with the genotype Ins/Ins identi¿ ed as a risk, p=0.02. 
Similarly, the distributions of the T174M and M235T genotypes were signi¿ -
cantly different between cases and controls (p=0.037 and 0.047, respectively) 
with 174M/M and 235T/T as the risky genotypes (p=0.001 and 0.026, respec-
tively). However, A1166C genotype frequencies were not signi¿ cantly diffe-
rent between patients and controls. In conclusion, our results suggest that a 
signi¿ cantly higher risk of CAD was associated with the Ins/Del, the M235T, 
and T174M polymorphisms; other environmental variables such as body mass 
index; and biochemical variables such as cholesterol. 
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The mineralocorticoid receptor (MR) is implicated in the development of 
myocardial ¿ brosis, cardiac arrhythmias and vascular dysfunction, both in 
animals and humans. In order to evaluate whether these effects are associated 
with a modi¿ cation in myocardial perfusion, we determined in vivo myocar-
dial basal perfusion as well as ‘coronary reserve’, using magnetic resonance 
imaging (MRI) measurements in MR-Cardio transgenic mice that conditio-
nally overexpress (tet-OFF system) the human MR speci¿ cally in cardiomyo-
cyte. The coronary reserve is de¿ ned as the difference between basal perfusion 
and maximal perfusion under stimulation of A2a adenosinergic receptors with 
the agonist ATL307 that induces vasodilatation.
Coronary reserve is strongly decreased in MR-Cardio mice (Ctrl=3.5±0.43 
vs. MR-Cardio=0.59±0.3 ml.min-1.g-1, P<0.01). This phenomenon is aldosterone 
dependent as far as the coronary reserve is restored in MR-Cardio mice by a 4 
weeks treatment with FAD286 (100 mg.kg-1.d-1), an inhibitor of the hormonal 
synthesis (Ctrl=2.43±0.48 vs. MR-Cardio=2.93±0.68 ml.min-1.g-1, NS). Of note, 
no difference in heart capillary density was observed among groups, indicating 
that MR overexpression in cardiomyocyte does not affect angiogenesis.
These results suggest that the MR expressed in cardiomyocyte participates 
to the regulation of coronary reserve in vivo. Moreover, experiments with 
FAD286 highlight the importance of aldosterone in this regulation. However, 
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After 2 weeks, arterial diameter increases in high flow (HF) compared 
to normal flow (NF) arteries in young ovariectomized rats treated with 
E2 (458±12 vs 374±8m), but not in untreated rats. The compensatory 
increase in wall mass accompanying diameter enlargement occurred in 
both groups, suggesting that E2 was involved only in the luminal expan-
sion. The involvement of E2 in remodeling requires activation of the 
estrogen receptor ERalpha. Importantly, inhibiting testosterone aromatiza-
tion into E2 in male rats with letrozole also suppressed remodeling and 
flow-mediated remodeling was altered in 12-month old rats compared to 
age-matched female.
In the other hand, Kinetics of inÀ ammatory markers, macrophage in¿ ltra-
tion, oxidative stress and MMPs activation were not affected (inÀ uenced) by 
E2 depletion. In contrast, E2 was required for the transient (day 4) increase in 
eNOS expression, as well as the concomitant decrease in caveolin-1 expres-
sion. Remodeling did not occur in eNOS knockout mice and was exagge-
rated in caveolin-1 knockout mice. Thus, we demonstrated for the ¿ rst time 
the essential role of E2 in blood À ow-induced remodeling of resistance arte-
ries. We also showed the important role of E2 in the NO production and 
caveaolin-1expression.
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Resistance arteries (RA) control local blood À ow. Chronic increases in 
blood À ow induce diameter enlargement (outward hypertrophic remodeling) 
of RA in response to growth, pregnancy, exercising as well as to compensate 
ischemia. As À ow-mediated outward remodeling of RA declines with age in 
male rats, not in female rats, we hypothesized that estrogens might play a role 
in this remodeling.
A surgical model eliciting an local increase in blood À ow in one mesenteric 
RA without other changes in pressure or circulating factors was performed in 
three-month old ovariectomized female rats treated or not with 17-beta-estra-
diol (E2). Changes in RA diameter were measured after 2 weeks and several 
mechanisms of remodeling were assessed after 2 or 4 days.
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